Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance.
Journal
Seminars in thrombosis and hemostasis
ISSN: 1098-9064
Titre abrégé: Semin Thromb Hemost
Pays: United States
ID NLM: 0431155
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
entrez:
12
10
2022
pubmed:
13
10
2022
medline:
15
10
2022
Statut:
ppublish
Résumé
Activated protein C (APC) resistance (APCR) is considered a risk factor of venous thromboembolism (VTE). The most common genetic disorder conferring APCR is a factor (F) V Leiden mutation, but many other factors are also implicated, such as other
Identifiants
pubmed: 36223771
doi: 10.1055/s-0042-1758162
doi:
Substances chimiques
Hormones
0
Protein C
0
Factor V
9001-24-5
Factor VIII
9001-27-8
Thrombin
EC 3.4.21.5
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
680-689Informations de copyright
Thieme. All rights reserved.
Déclaration de conflit d'intérêts
Dr. Bouvy reports other from QUALIblood, during the conduct of the study; Dr. Douxfils reports other from Qualiblood, during the conduct of the study; personal fees from Stago Diagnostica, personal fees from Daiichi-Sankyo, personal fees from Portola, personal fees from Roche, personal fees from Roche Diagnostics, personal fees from DOASENSE, personal fees from Mithra Pharmaceuticals, personal fees from Estetra, personal fees from Werfen, personal fees from Technoclone, outside the submitted work; Dr. Morimont reports other from QUALIblood, during the conduct of the study; and Dr. Donis reports other from QUALIblood, during the conduct of the study. The remaining authors do not report any conflicts of interests.